ARCHIVES

NCAB Jolted By 1977 Prelim Budget, “Outrageous” Prospect – Funding Only 30% Of Approved Grants

This article is from The Cancer Letter archive.

Vol. 01 No. 26 | June 27, 1975

Download PDF Visit The Full Archive

Related Articles

NCAB Subcommittee Calls For Review Of Organ Site Program, Consideration Of One For Lung Cancer

May 1, 1981

Gleevec To Prevent Recurrence Of Gastrointestinal Cancer

December 26, 2008

DCBD Board Approved Concepts For New Grants In Cytogenetics Solid Tumor Diagnoses

December 13, 1984

FDA orders “limited distribution” for lung cancer drug Iressa.

June 24, 2005

NCAB Hears “Impressive” Progress Reports, Including Treatment for Breast, Liver Cancer, Vaccine Studies

October 18, 1974

OAM Advisor’s Faxes Promote Alternatives, Cassileth Writes To NIH

September 3, 1993